The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder

European Journal of Pharmacology

Volumn 570, Issue 1-3, 2007, Pages 182-187

  Saitoh, Chikashi ^a,b   Kitada, Chika ^a   Uchida, Wataru ^a   Chancellor, Michael B ^b   de Groat, William C ^b   Yoshimura, Naoki ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anandamide; Capsaicin; Prostanoid EP1 receptor; Rat; TRPV1; Urinary bladder

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; ATROPINE; CAPSAICIN; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; INDOMETACIN; NOLPITANTIUM; SAREDUTANT; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ISOLATION PROCEDURE; MALE; MUSCLE EXCITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SMOOTH MUSCLE CONTRACTILITY;

ANIMALS; ARACHIDONIC ACIDS; CAPSAICIN; ENDOCANNABINOIDS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, PROSTAGLANDIN E; TRPV CATION CHANNELS; URINARY BLADDER;

EID: 34547828233     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.016     Document Type: Article

References (32)

1. Avelino A., and Cruz F. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn-Schmiedebergs Arch. Pharmacol. 373 (2006) 287-299
2. 1 using a fluorometric imaging plate reader (FLIPR) assay. Br. J. Pharmacol. 141 (2004) 737-745
3. Birder L.A., Nakamura Y., Kiss S., Nealen M.L., Barrick S., Kanai A.J., Wang E., Ruiz G., de Groat W.C., Apodaca G., Watkins S., and Caterina M.J. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci. 5 (2002) 856-860
4. Burstein S.H., Rossetti R.G., Yagen B., and Zurier R.B. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 61 (2000) 29-41
5. Capasso R., and Tavares I.A. Effect of the flavonoid galangin on urinary bladder rat contractility in-vitro. J. Pharm. Pharmacol. 54 (2002) 1147-1150
6. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
7. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
8. Craib S.J., Ellington H.C., Pertwee R.G., and Ross R.A. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol. 134 (2001) 30-37
9. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., and Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405 (2000) 183-187
10. de Groat W.C. A neurologic basis for the overactive bladder. Urology 50 (1997) 36-52
11. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
12. Dinis P., Charrua A., Avelino A., Yaqoob M., Bevan S., Nagy I., and Cruz F. Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J. Neurosci. 24 (2004) 11253-11263
13. Harrison S., De Petrocellis L., Trevisani M., Benvenuti F., Bifulco M., Geppetti P., and Di Marzo V. Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder. Eur. J. Pharmacol. 475 (2003) 107-114
14. Ho W.S., and Randall M.D. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br. J. Pharmacol. 150 (2007) 641-651
15. 1 receptors during urinary bladder inflammation in rats. Biomed. Res. 27 (2006) 49-54
16. Kagaya M., Lamb J., Robbins J., Page C.P., and Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137 (2002) 39-48
17. Kojima S., Sugiura T., Waku K., and Kamikawa Y. Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro. Eur. J. Pharmacol. 444 (2002) 203-207
18. Maggi C.A., Santicioli P., and Meli A. Evidence for the involvement of endogenous substance P in the motor effects of capsaicin on the rat urinary bladder. J. Pharm. Pharmacol. 37 (1985) 203-204
19. Maggi C.A., Patacchini R., Santicioli P., and Giuliani S. Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br. J. Pharmacol. 103 (1991) 1535-1541
20. Nagy I., Santha P., Jancso G., and Urban L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol. 500 (2004) 351-369
21. 2 ethanolamide. J. Pharmacol. Exp. Ther. 301 (2002) 900-907
22. Santicioli P., Maggi C.A., and Meli A. Functional evidence for the existence of a capsaicin-sensitive innervation in the rat urinary bladder. J. Pharm. Pharmacol. 38 (1986) 446-451
23. Sarau H.M., Griswold D.E., Potts W., Foley J.J., Schmidt D.B., Webb E.F., Martin L.D., Brawner M.E., Elshourbagy N.A., Medhurst A.D., Giardina G.A., and Hay D.W. Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. J. Pharmacol. Exp. Ther. 281 (1997) 1303-1311
24. Sculptoreanu A., de Groat W.C., Buffington C.A., and Birder L.A. Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp. Neurol. 193 (2005) 437-443
25. 1). Br. J. Pharmacol. 129 (2000) 227-230
26. Trevisani M., Patacchini R., Nicoletti P., Gatti R., Gazzieri D., Lissi N., Zagli G., Creminon C., Geppetti P., and Harrison S. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. 145 (2005) 1123-1131
27. Tucker R.C., Kagaya M., Page C.P., and Spina D. The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br. J. Pharmacol. 132 (2001) 1127-1135
28. Valenzano K.J., Grant E.R., Wu G., Hachicha M., Schmid L., Tafesse L., Sun Q., Rotshteyn Y., Francis J., Limberis J., Malik S., Whittemore E.R., and Hodges D. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J. Pharmacol. Exp. Ther. 306 (2003) 377-386
29. Vizzard M.A. Alterations in spinal cord Fos protein expression induced by bladder stimulation following cystitis. Am. J. Physiol., Regul. Integr. Comp. Physiol. 278 (2000) R1027-R1039
30. Wahn H., Wolf J., Kram F., Frantz S., and Wagner J.A. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. Am. J. Physiol., Heart Circ. Physiol. 289 (2005) H2491-H2496
31. White R., Ho W.S., Bottrill F.E., Ford W.R., and Hiley C.R. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 134 (2001) 921-929
32. 3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats. Neuropharmacology 39 (2000) 141-149